KR970064584A - 동결건조된 백신 성분을 함유하는 용기 - Google Patents
동결건조된 백신 성분을 함유하는 용기 Download PDFInfo
- Publication number
- KR970064584A KR970064584A KR1019970007346A KR19970007346A KR970064584A KR 970064584 A KR970064584 A KR 970064584A KR 1019970007346 A KR1019970007346 A KR 1019970007346A KR 19970007346 A KR19970007346 A KR 19970007346A KR 970064584 A KR970064584 A KR 970064584A
- Authority
- KR
- South Korea
- Prior art keywords
- vaccine
- container according
- component
- container
- lysate
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims abstract 20
- 229940124856 vaccine component Drugs 0.000 claims abstract 9
- 238000004519 manufacturing process Methods 0.000 claims abstract 3
- 239000006166 lysate Substances 0.000 claims 5
- 239000011159 matrix material Substances 0.000 claims 2
- 244000052769 pathogen Species 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Packages (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
- Drying Of Solid Materials (AREA)
Abstract
본 발명은 하나 이상의 동결건조된 백신 성분을 함유하는 백신 용기에 관한 것이다. 백신 성분(들)은 두 개 이상의 동결건조체(이들 동결건조체 중 하나 이상은 용해구(溶解球 : lyosphere)임) 내에 존재한다. 또한, 본 발명은 상기 백신 용기의 제조방법에 관한 것이다. 또한, 본 발명은 백신 용기를 포함하는 백신 팩에 관한 것이다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (12)
- 하나 이상의 동결건조된 백신 성분을 함유하는 백신 용기로서, 상기 백신 성분(들)은 두 개 이상의 동결건조체 내에 존재하며, 상기 동결건조체 중 하나 이상은 용해구임을 특징으로 하는 백신 용기.
- 제1항에 있어서, 상기 동결건조체가 용해구임을 특징으로 하는 백신 용기.
- 제1항 또는 제2항에 있어서, 상기 하나 이상의 동결건조체가 하나의 단일 백신 성분을 포함하는 것을 특징으로 하는 백신 용기.
- 제1항 내지 제3항 중 어느 한 항에 있어서, 상기 동결건조체 각각이 하나의 단일 백신 성분을 포함하는 것을 특징으로 하는 백신 용기.
- 제1항 내지 제4항 중 어느 한 항에 있어서, 상기 백신 성분이 두 개 이상의 병원체로부터 유도된 것임을 특징으로 하는 백신 용기.
- 제1항 내지 제5항 중 어느 한 항에 있어서, 상기 용해구의 직경이 1 내지 10㎜임을 특징으로 하는 백신 용기.
- 제1항 내지 제6항 중 어느 한 항에 있어서, 상기 동결건조체 각각이 상기 용해구의 내용물을 표시하는 색으로 착색됨을 특징으로 하는 백신 용기.
- 제1항 내지 제7항 중 어느 한 항에 있어서, 상기 동결건조체 중 하나 이상이 강성 매트릭스를 포함함을 특징으로 하는 백신 용기.
- 제8항에 있어서, 상기 매트릭스가 백신 성분의 느린 방출을 가능하게 함을 특징으로 하는 백신 용기.
- 제1항 백신 용기를 제조하는 방법으로서, 하나 이상의 백신 성분을 포함하는 다른 동결건조체를 포함하는 용기에 하나 이상의 백신 성분을 포함하는 하나 이상의 용해구를 첨가하는 단계를 포함하는 것을 특징으로 하는 방법.
- 제2항에 따른 백신 용기를 제조하는 방법으로서, 용기에 하나 이상의 백신 성분을 포함하는 두 개 이상의 용해구를 첨가하는 단계를 포함하는 것을 특징으로 하는 방법.
- 제1항 내지 제9항의 백신 용기를 포함하는 백신 팩.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96200621.9 | 1996-03-07 | ||
EP96200621 | 1996-03-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR970064584A true KR970064584A (ko) | 1997-10-13 |
KR100458370B1 KR100458370B1 (ko) | 2005-07-07 |
Family
ID=8223754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970007346A KR100458370B1 (ko) | 1996-03-07 | 1997-03-06 | 동결건조된백신성분을함유하는용기 |
Country Status (19)
Country | Link |
---|---|
US (2) | US5897852A (ko) |
EP (1) | EP0799613B1 (ko) |
JP (1) | JP4293643B2 (ko) |
KR (1) | KR100458370B1 (ko) |
CN (1) | CN1133423C (ko) |
AT (1) | ATE202925T1 (ko) |
AU (1) | AU704629B2 (ko) |
CA (1) | CA2198195C (ko) |
DE (1) | DE69705569T2 (ko) |
DK (1) | DK0799613T3 (ko) |
EG (1) | EG23992A (ko) |
ES (1) | ES2161412T3 (ko) |
GR (1) | GR3036725T3 (ko) |
HU (1) | HU220532B1 (ko) |
IL (1) | IL120202A (ko) |
NZ (1) | NZ314267A (ko) |
PT (1) | PT799613E (ko) |
SA (1) | SA97170715B1 (ko) |
ZA (1) | ZA971734B (ko) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL120202A (en) * | 1996-03-07 | 2001-03-19 | Akzo Nobel Nv | Container with freeze-dried vaccine components |
AU779403B2 (en) * | 1999-08-24 | 2005-01-20 | Teva Pharmaceutical Industries Ltd. | A vaccine composition and method of using the same |
US6592869B2 (en) | 1999-08-24 | 2003-07-15 | Teva Pharmaceutical Industries, Ltd. | Vaccine composition and method of using the same |
US7863012B2 (en) * | 2004-02-17 | 2011-01-04 | Veridex, Llc | Analysis of circulating tumor cells, fragments, and debris |
AUPR750501A0 (en) * | 2001-09-05 | 2001-09-27 | Gauci, Mark | Products comprising quantum of bioparticles and method for production thereof |
US6780581B2 (en) | 2001-09-12 | 2004-08-24 | Btf Pty Ltd | Products comprising quantum of bioparticles and method for production thereof |
US20140248273A1 (en) | 2001-09-08 | 2014-09-04 | Jos van Strijp | Vaccine based on staphylococcal superantigen-like 3 protein (ssl3) |
RU2006126051A (ru) * | 2003-12-19 | 2008-01-27 | Альк-Абелло А/С (Dk) | Способы получения партии активного фармацевтического ингредиента, контейнер, содержащий криогранулы аллергенного продукта, и криогранула аллергенного продукта |
US20050181353A1 (en) * | 2004-02-17 | 2005-08-18 | Rao Galla C. | Stabilization of cells and biological specimens for analysis |
TWI436789B (zh) * | 2008-01-21 | 2014-05-11 | Intervet Int Bv | 含有藥學化合物的顆粒之冷凍乾燥方法及含有此顆粒的藥學包 |
TWI444384B (zh) * | 2008-02-20 | 2014-07-11 | Gilead Sciences Inc | 核苷酸類似物及其在治療惡性腫瘤上的用途 |
CA2716399C (en) | 2008-03-05 | 2020-07-21 | Pierre Chouvenc | Process for stabilizing an adjuvant containing vaccine composition |
EP2143440A1 (fr) | 2008-07-09 | 2010-01-13 | Sanofi Pasteur | Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués |
TW201043267A (en) * | 2009-03-19 | 2010-12-16 | Intervet Int Bv | In situ constituting a vaccine for administration to a predetermined herd of animals |
EP2658568A1 (en) | 2010-12-29 | 2013-11-06 | Intervet International B.V. | Canine babesiosis vaccine antigen |
WO2013066769A1 (en) | 2011-10-31 | 2013-05-10 | Merck Sharp & Dohme Corp. | Methods of preparing lyophilized spherical-shaped pellets of biological materials |
US10617650B2 (en) * | 2015-10-16 | 2020-04-14 | Merck Sharp & Dohme Corp. | Process for preparing formulations for gastrointestinal-targeted therapies |
NL2018155B1 (en) | 2017-01-11 | 2018-07-25 | Intervet Int Bv | Oral vaccine against ruminant respiratory disease |
CN113862332A (zh) * | 2021-09-17 | 2021-12-31 | 浙江大学 | 琼脂糖在制备生物大分子冻干保护剂中的应用 |
CN114159555A (zh) * | 2021-12-08 | 2022-03-11 | 江西赛基生物技术有限公司 | 抗原蛋白冻干小球及其制备方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3655838A (en) * | 1969-03-20 | 1972-04-11 | Organon | Method of pelletizing analytical or immunological reagents |
US3932943A (en) * | 1970-08-14 | 1976-01-20 | E. I. Du Pont De Nemours And Company | Method of preparation of lyophilized biological products |
SE425461B (sv) * | 1971-09-03 | 1982-10-04 | Du Pont | Sett att framstella en homogen, lyofiliserad produkt av blodserum eller blodplasma |
US3857423A (en) * | 1971-12-27 | 1974-12-31 | W Ronca | Topical medicament kit with interlocking components |
US3893280A (en) * | 1972-06-21 | 1975-07-08 | Burns Biotec Lab Inc | Transfer packaging for biologicals |
US4351158A (en) * | 1980-01-22 | 1982-09-28 | American Home Products Corporation | Method of producing multicomponent lyophilized product |
US4295280A (en) * | 1980-03-17 | 1981-10-20 | American Home Products Corporation | Method of obtaining a lyophilized product |
US4981685A (en) * | 1986-03-07 | 1991-01-01 | Utah State University Foundation | Bacterial extract vaccines for veterinary application |
US4712310A (en) * | 1986-09-15 | 1987-12-15 | E. I. Du Pont De Nemours And Company | Co-spray technique |
IL86180A (en) | 1987-05-04 | 1992-08-18 | Merck & Co Inc | Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines |
AT390192B (de) * | 1988-08-29 | 1990-03-26 | Immuno Ag | Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobuling-h|ltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen |
US5044091B1 (en) * | 1989-04-18 | 1997-12-30 | Sankyo Co | Method of preparing a freeze-dried formulation of a drug |
CA2030551C (en) * | 1989-05-01 | 1998-08-25 | Wayne Gombotz | Process for producing small particles of biologically active molecules |
IE64738B1 (en) | 1990-03-20 | 1995-09-06 | Akzo Nv | Stabilized gonadotropin containing preparations |
US5270057A (en) * | 1990-03-20 | 1993-12-14 | Akzo N.V. | Stabilized gonadotropin containing preparations |
CA2051092C (en) * | 1990-09-12 | 2002-07-23 | Stephen A. Livesey | Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions |
JPH08509483A (ja) * | 1993-04-28 | 1996-10-08 | アクゾ・ノベル・エヌ・ベー | ゴナドトロピンを含有するライオスフィア |
IL120202A (en) * | 1996-03-07 | 2001-03-19 | Akzo Nobel Nv | Container with freeze-dried vaccine components |
-
1997
- 1997-02-11 IL IL12020297A patent/IL120202A/xx not_active IP Right Cessation
- 1997-02-19 NZ NZ314267A patent/NZ314267A/en not_active IP Right Cessation
- 1997-02-21 US US08/803,660 patent/US5897852A/en not_active Expired - Lifetime
- 1997-02-21 CA CA002198195A patent/CA2198195C/en not_active Expired - Lifetime
- 1997-02-27 ZA ZA9701734A patent/ZA971734B/xx unknown
- 1997-03-01 EG EG15097A patent/EG23992A/xx active
- 1997-03-05 ES ES97200647T patent/ES2161412T3/es not_active Expired - Lifetime
- 1997-03-05 DE DE69705569T patent/DE69705569T2/de not_active Expired - Lifetime
- 1997-03-05 AT AT97200647T patent/ATE202925T1/de active
- 1997-03-05 DK DK97200647T patent/DK0799613T3/da active
- 1997-03-05 EP EP97200647A patent/EP0799613B1/en not_active Expired - Lifetime
- 1997-03-05 PT PT97200647T patent/PT799613E/pt unknown
- 1997-03-06 CN CNB971029288A patent/CN1133423C/zh not_active Expired - Lifetime
- 1997-03-06 HU HU9700556A patent/HU220532B1/hu not_active IP Right Cessation
- 1997-03-06 AU AU15149/97A patent/AU704629B2/en not_active Ceased
- 1997-03-06 KR KR1019970007346A patent/KR100458370B1/ko not_active IP Right Cessation
- 1997-03-07 JP JP05350097A patent/JP4293643B2/ja not_active Expired - Lifetime
- 1997-03-15 SA SA97170715A patent/SA97170715B1/ar unknown
-
1999
- 1999-02-17 US US09/252,625 patent/US6106836A/en not_active Expired - Lifetime
-
2001
- 2001-09-27 GR GR20010401579T patent/GR3036725T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
HU9700556D0 (en) | 1997-04-28 |
ATE202925T1 (de) | 2001-07-15 |
NZ314267A (en) | 1998-01-26 |
JPH1024090A (ja) | 1998-01-27 |
ES2161412T3 (es) | 2001-12-01 |
KR100458370B1 (ko) | 2005-07-07 |
DK0799613T3 (da) | 2001-10-22 |
EP0799613B1 (en) | 2001-07-11 |
US5897852A (en) | 1999-04-27 |
AU1514997A (en) | 1997-09-11 |
ZA971734B (en) | 1997-09-09 |
CN1133423C (zh) | 2004-01-07 |
GR3036725T3 (en) | 2001-12-31 |
HUP9700556A3 (en) | 2000-04-28 |
DE69705569T2 (de) | 2002-05-16 |
IL120202A0 (en) | 1997-06-10 |
EP0799613A1 (en) | 1997-10-08 |
PT799613E (pt) | 2001-12-28 |
IL120202A (en) | 2001-03-19 |
AU704629B2 (en) | 1999-04-29 |
CA2198195C (en) | 2005-10-25 |
CA2198195A1 (en) | 1997-09-07 |
CN1163102A (zh) | 1997-10-29 |
JP4293643B2 (ja) | 2009-07-08 |
EG23992A (en) | 2008-03-09 |
HUP9700556A2 (en) | 1997-12-29 |
US6106836A (en) | 2000-08-22 |
DE69705569D1 (de) | 2001-08-16 |
HU220532B1 (hu) | 2002-03-28 |
SA97170715B1 (ar) | 2006-10-11 |
MX9701726A (es) | 1998-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR970064584A (ko) | 동결건조된 백신 성분을 함유하는 용기 | |
GB2319836B (en) | Microplates | |
RU94007635A (ru) | Комбинированный препарат для контрацепции | |
BR0017112A (pt) | Produto detergente | |
KR950007856A (ko) | 경구 투여용 라파마이신 제형 | |
HUP9900346A2 (hu) | Avermektineket és depszipeptideket tartalmazó endoparazita ellenes hatású gyógyászati készítmények | |
BR9914343B1 (pt) | compósito dental, e, processo de preparação de um compósito dental compreendendo uma composição polimerizada. | |
NZ316787A (en) | Methods and compositions for the selective modification of nucleic acids | |
ES2131556T3 (es) | Fibra aglutinable termicamente para telas no tejidas de alta resistencia. | |
ID27457A (id) | Komposisi untuk pengobatan hiv dan infeksi virus lainnya | |
AR004357A1 (es) | Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos. | |
BR9502555A (pt) | Composiçao que consiste de um dendrímero e de uma substancia ativa ocluida no dendrímero processo para a preparaçao de uma tal composiçao e processo para liberaçao de uma substancia ativa | |
PT1318791E (pt) | Composicao farmaceutica semi-solida de isotretinoina | |
CA2338684A1 (en) | Injectable propofol formulations | |
ATE91262T1 (de) | Geblasene, einstueckige flasche und verfahren zur herstellung derselben. | |
BR0105802A (pt) | Composição de tintura de oxidação das fibras queratìnicas compreendendo derivados de para-fenilenodiamina com grupo pirrolidinila, processo de tintura de oxidação das mesmas, dispositivos com vários compartimentos, ou "kit" de tintura com vários compartimentos e, produto colorido resultante da oxidação | |
DE69624364D1 (de) | Abführmittel enthaltend lactitol und psyllium | |
GB0117783D0 (en) | Illumination method illumination system and the components thereof, especially for illuminating hollow bodies such as signs inscriptions letters especially r | |
ES2096988T3 (es) | Organopolisiloxanos que contienen grupos hidrofilos. | |
BR9908195A (pt) | Derivado do grupo b das estreptograminas, processo para a preparação do mesmo, composições farmacêuticas, e, associações de derivados de estreptograminas. | |
BR9917242B1 (pt) | processo para a polimerização de uma olefina e/ou uma olefina e pelo menos uma ou mais outra(s) olefina(s), e, processo para redução da carga eletrostática gerada na polimerização de uma olefina e/ou uma olefina e pelo menos uma ou mais outra(s) olefina(s). | |
PT633928E (pt) | Microrganismos processo de preparacao e utilizacao | |
ES2098407T3 (es) | Procedimiento para la obtencion de caprolactama mediante transposicion de beckmann de ciclohexanonoxima. | |
ES2183169T3 (es) | Hidrogenofluorosulfonatos de base organica, su utilizacion para liberar las bases organicas de su fluorhidrato, su procedimiento de preparacion, composicion que los contiene. | |
BR9805110A (pt) | Dispositivo para acoplamento ou separação de uma embreagem de arraste |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121030 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20131030 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20141030 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20150930 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20161028 Year of fee payment: 13 |
|
EXPY | Expiration of term |